Clinical implications of the log linear association between LDL-C lowering and cardiovascular risk reduction: Greatest benefits when LDL-C >100 mg/dl

BACKGROUND: The log linear association between on-treatment LDL-C levels and ASCVD events is amplified in higher risk patient subgroups of statin versus placebo trials. OBJECTIVES: Update previous systematic review to evaluate how the log linear association influences the magnitude of cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Robinson, Jennifer G., Jayanna, Manju Bengaluru, Bairey Merz, C. Noel, Stone, Neil J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595281/
https://www.ncbi.nlm.nih.gov/pubmed/33119602
http://dx.doi.org/10.1371/journal.pone.0240166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595281/
https://www.ncbi.nlm.nih.gov/pubmed/33119602
http://dx.doi.org/10.1371/journal.pone.0240166

Ejemplares similares